Revisiting the concept of neoadjuvant and induction therapy in head and neck cancer with the advent of immunotherapy-Reference-Cited by-同舟云学术

Revisiting the concept of neoadjuvant and induction therapy in head and neck cancer with the advent of immunotherapy

Published:2023-12 Issue: Volume:121 Page:102644
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Smussi Davide^ORCID,Mattavelli Davide,Paderno Alberto,Gurizzan Cristina,Lorini Luigi,Romani Chiara,Bignotti Eliana,Grammatica Alberto,Ravanelli Marco,Bossi Paolo^ORCID

Funder

Fondazione Italiana per la Ricerca sul Cancro Airc

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference65 articles.

1. Head and neck cancer;Argiris;Lancet,2008

2. Mixed treatment comparison meta-analysis of altered fractionated radiotherapy and chemotherapy in head and neck cancer;Blanchard;J Clin Epidemiol,2011

3. Induction chemotherapy in head and neck cancers: Results and controversies;Gau;Oral Oncol,2019

4. Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma;Zhong;J Clin Oncol,2013

5. Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group;Blanchard;J Clin Oncol,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prognostic role of salivary miRNAs in oral squamous cell carcinoma: technical challenges and clinical perspectives;Acta Otorhinolaryngologica Italica;2024-09

2. Clinical validation of a tissue-agnostic genome-wide methylome enrichment MRD assay for head and neck malignancies;Annals of Oncology;2024-09

3. Prediction of nodal disease in oral squamous cell carcinoma of the tongue: histopathological risk assessment with the focus on depth of invasion;Clinical Oral Investigations;2024-08-06

4. PLCXD2 expression relates to the immune microenvironment and prognosis of head and neck squamous cell carcinoma;2024-05-10

5. The Evolving Paradigm of Immunotherapy in Head-and-neck Squamous Cell Cancers;Journal of Head & Neck Physicians and Surgeons;2024-01